Skip to main content
VCbacked
Log inGet Started

TenSixteen Bio

San Francisco, United States

TenSixteen Bio is a biotechnology company focused on developing novel therapeutics for a variety of diseases.

$40.0M raised
Jan 2022
Series A
BiotechnologyHealth CareTherapeutics

Top Investors

Foresite CapitalGoogle Ventures

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about TenSixteen Bio

How much funding has TenSixteen Bio raised?
TenSixteen Bio has raised $40.0M in total funding. The most recent round was Series A. The last funding was announced in January 2022.
Who are TenSixteen Bio's investors?
TenSixteen Bio's investors include Foresite Capital, Google Ventures.
Where is TenSixteen Bio headquartered?
TenSixteen Bio is headquartered in San Francisco, United States.
What does TenSixteen Bio do?
TenSixteen Bio is a biotechnology company focused on developing novel therapeutics for a variety of diseases.
What stage is TenSixteen Bio at?
TenSixteen Bio is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"TenSixteen Bio — Funding & Investors." VCBacked, January 27, 2022, https://www.vcbacked.co/company/tensixteen-bio. Accessed July 4, 2026.
APA
VCBacked. (2022). TenSixteen Bio — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/tensixteen-bio
Wikipedia (cite web)
{{cite web |title=TenSixteen Bio — Funding & Investors |url=https://www.vcbacked.co/company/tensixteen-bio |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K